Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cellsElena Ciaglia, Maurizio Bifulco|Oncotarget|2015Cited by 54
Antiglioma effects of<scp>N</scp>6‐isopentenyladenosine, an endogenous isoprenoid end product, through the downregulation of epidermal growth factor receptorElena Ciaglia, Maurizio Bifulco|International Journal of Cancer|2016Cited by 34
N6-Isopentenyladenosine Enhances the Radiosensitivity of Glioblastoma Cells by Inhibiting the Homologous Recombination Repair Protein RAD51 ExpressionGiovanna Navarra, Maurizio Bifulco|Frontiers in Oncology|2020Cited by 15
The isoprenoid end product N6-isopentenyladenosine reduces inflammatory response through the inhibition of the NFκB and STAT3 pathways in cystic fibrosis cellsAntonietta Santoro, Maurizio Bifulco|Inflammation Research|2017Cited by 14
<scp>N6</scp>‐isopentenyladenosine inhibits aerobic glycolysis in glioblastoma cells by targeting <scp>PKM2</scp> expression and activityCristina Pagano, Maurizio Bifulco|FEBS Open Bio|2024Cited by 6